Finance

Lists
Outlook: 9.1% bullish·18.2% bearish
Go to analysis
TRV:NYSE
Travelers Companies Inc
$360.61
-0.01%
(-0.030) 1D
$360.61
0.00% (0.00)
After hours
Closed: Oct 7, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRV...
Open
$358.84
High
$364.34
Low
$357.09
Mkt. cap
75.21B
Avg. vol.
1.35M
Volume
0.00
Dividend
1.39%
Quarterly dividend
$1.25
Ex-dividend date
Sep 10, 2026
P/E ratio
9.65
52-wk high
$398.70
52-wk low
$252.26
EPS
$37.36
Beta
0.43
Shares outstanding
208.58M
No. of employees
34K
Open
$358.84
High
$364.34
Low
$357.09
Mkt. cap
75.21B
Avg. vol.
1.35M
Volume
0.00
Dividend
1.39%
Quarterly dividend
$1.25
Ex-dividend date
Sep 10, 2026
P/E ratio
9.65
52-wk high
$398.70
52-wk low
$252.26
EPS
$37.36
Beta
0.43
Shares outstanding
208.58M
No. of employees
34K
News stories
From web sources and news partners
Profile
The Travelers Companies, Inc., commonly known as Travelers, is an American multinational insurance company. It is the second-largest writer of U.S. commercial property and casualty insurance, and the sixth-largest writer of U.S. personal insurance through independent agents. Travelers is incorporated in Minnesota, with headquarters in New York City, and its largest office in Hartford, Connecticut. It has been a component of the Dow Jones Industrial Average since June 8, 2009. The company has field offices in every U.S. state, plus operations in the United Kingdom, Ireland, Singapore, China, Canada, and Brazil. Travelers ranked No. 98 in the 2021 Fortune 500 list of the largest United States corporations with total revenue of $32 billion. Wikipedia
About Travelers Companies Inc
CEOAlan D. Schnitzer
Employees34K
Founded1853
Headquarters-
SectorInsurance
Websitetravelers.com
Analyst ratings
Based on 20 analysts giving stock ratings to TRV in the past 3 months
Hold
Buy
4
Hold
11
Sell
5
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for TRV in the last 3 months.
Highest
Current $360.61
$425.00 (+17.86%)
Average
$361.94 (+0.37%)
Lowest
$297.00 (-17.64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Tunis
Cantor Fitzgerald
Buy
Maintained
$378.00
+4.8%
10/07/2026
Yaron Kinar
Mizuho Securities
Hold
Maintained
$345.00
-4.3%
10/07/2026
Vikram Gandhi
HSBC
Hold
Maintained
$376.00
+4.3%
10/07/2026
Alex Scott
Barclays
Sell
Maintained
$318.00
-11.8%
10/07/2026
Bob Huang
Morgan Stanley
Sell
Reiterated
$330.00
-8.5%
10/06/2026
Joshua Shanker
Bank of America Securities
Sell
Maintained
-
-
10/01/2026
Brian Meredith
UBS
Hold
Maintained
$383.00
+6.2%
09/28/2026
Paul Newsome
Piper Sandler
Buy
Maintained
$405.00
+12.3%
09/28/2026
Michael Zaremski
BMO Capital
Hold
Reiterated
$379.00
+5.1%
09/23/2026
David Motemaden
Evercore ISI
Hold
Maintained
$342.00
-5.2%
09/21/2026
Pablo Singzon
J.P. Morgan
Hold
Maintained
$348.00
-3.5%
07/28/2026
Mark Hughes
Truist Financial
Buy
Maintained
-
-
07/22/2026
Cave Montazeri
Deutsche Bank
Hold
Maintained
$363.00
+0.7%
07/21/2026
Harry Fong
Roth MKM
Buy
Maintained
$425.00
+17.9%
07/21/2026
Meyer Shields
KBW
Hold
Maintained
$373.00
+3.4%
07/21/2026
Robert Cox CFA
Goldman Sachs
Sell
Downgraded
$350.00
-2.9%
07/20/2026
Matthew Heimermann
Citi
Hold
Maintained
$385.00
+6.8%
07/20/2026
Elyse Greenspan
Wells Fargo
Hold
Maintained
$356.00
-1.3%
07/20/2026
Adam Klauber
William Blair
Hold
Maintained
-
-
07/17/2026
Unknown Analyst
TD Cowen
Sell
Downgraded
$297.00
-17.6%
07/13/2026
Andrew Kligerman
TD Cowen
Sell
Downgraded
$297.00
-17.6%
07/13/2026
Gregory Peters
Raymond James
Buy
Maintained
$400.00
+10.9%
07/06/2026
Jimmy Bhullar
J.P. Morgan
Hold
Upgraded
$322.00
-10.7%
05/26/2026
Kevin Heal
Argus Research
Buy
Reiterated
$330.00
-8.5%
04/17/2026
Next call in 8 days
Fri, Oct 16, 3:00 PM
Fiscal period
Q3 2026
EPS / Est. (USD)
- / $7.30
Revenue / Est. (USD)
- / 11.02B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
12.47B
12.43B
11.92B
12.15B
Cost of goods sold
8.44B
7.67B
8.15B
7.71B
Cost of revenue
8.44B
7.67B
8.15B
7.71B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.57B
1.54B
1.54B
1.56B
Operating expense
1.57B
1.54B
1.54B
1.56B
Total operating expenses
10.02B
9.21B
9.69B
9.27B
Operating income
2.46B
3.22B
2.24B
2.88B
Other non operating income
-
-
-
-
EBT including unusual items
2.34B
3.10B
2.12B
2.77B
EBT excluding unusual items
2.34B
3.10B
2.12B
2.77B
Income tax expense
456.00M
607.00M
408.00M
559.00M
Effective tax rate
19.45%
19.56%
19.25%
20.20%
Other operating expenses
-
-
-
-
Net income
1.89B
2.50B
1.71B
2.21B
Net profit margin
15.14%
20.08%
14.35%
18.17%
Earnings per share
8.14
11.13
7.71
10.04
Interest and investment income
-
-
-
-
Interest expense
-111.00M
-116.00M
-116.00M
-113.00M
Net interest expenses
-111.00M
-116.00M
-116.00M
-113.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.62B
3.38B
2.43B
3.05B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps